DOI: 10.1126/science.adu2987 Eduardo Fernández, Nanowires replace lost retinal cells, Science (2025). DOI: 10.1126/science.ady4439 ...

According to Adrián González Guillén, a snail expert and photographer based in Cuba, the CITES ban hasn’t stopped the illegal trade, mainly to the U.S. and Spain and to various Asian countries.

Total potential deal value of $110 million plus royaltiesKiora to receive an immediate $1.25 million exclusive option feeIf the option is exercised, Kiora will receive an additional mid-single ...

MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that ...

News-Medical is your trusted source of Macular Degeneration news, articles and research for doctors, patients, and families.

Both unadjusted and adjusted Cox proportional hazard models estimated higher risk for neovascular age-related macular degeneration among patients exposed to GLP-1 medication (hazard ratio [HR], 2. ...

Article Published: May 1998 Molecular genetics of human retinal dystrophies Chris F Inglehearn Eye 12, 571–579 (1998) Cite this article ...

Worldwide, 1 in 3,000 people suffer from IRDs, which cause progressive vision loss and retinal degeneration. So far, 326 of the roughly 20,000 human genes have been linked to these disorders.

Advances in Cataract Surgery Majed Alkharashi; Walter J Stark; Yassine J Daoud Disclosures Expert Rev Ophthalmol. 2013;8 (5):447-456. Peripheral Corneal Relaxing Incisions ...

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a Phase 2/3 pivotal confirmatory trial of OCU410ST, an innovative … ...

Roche's Genentech unit has won FDA approval for Susvimo, an implant for eyesight-robbing disease wet age-related macular degeneration (AMD) that gives patients an alternative to regular injections ...